Tekla World Healthcare Fund
Name
As of 06/01/2026Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
Vitals
YTD Return
2.3%
1 yr return
36.5%
3 Yr Avg Return
12.1%
5 Yr Avg Return
7.6%
Net Assets
$497 M
Holdings in Top 10
41.5%
52 WEEK LOW AND HIGH
Expenses
OPERATING FEES
Expense Ratio 1.74%
SALES FEES
Front Load N/A
Deferred Load N/A
TRADING FEES
Turnover 69.37%
Redemption Fee N/A
Min Investment
Standard (Taxable)
N/A
IRA
N/A
Fund Classification
Fund Type
Closed-end mutual fund
Name
As of 06/01/2026Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
XTHWX - Profile
Distributions
- YTD Total Return 2.3%
- 3 Yr Annualized Total Return 12.1%
- 5 Yr Annualized Total Return 7.6%
- Capital Gain Distribution Frequency N/A
- Net Income Ratio 0.53%
- Dividend Yield 11.1%
- Dividend Distribution Frequency Monthly
Fund Details
-
Legal NameTekla World Healthcare Fund
-
Fund Family NameTekla Capital Management LLC
-
Inception DateJul 01, 2015
-
Shares Outstanding37401893
-
Share ClassOther
-
CurrencyUSD
-
Domiciled CountryUnited States
-
ManagerDaniel Omstead
Fund Description
XTHWX - Performance
Return Ranking - Trailing
| Period | XTHWX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 2.3% | -22.9% | 20.0% | 24.38% |
| 1 Yr | 36.5% | -20.4% | 134.5% | 23.13% |
| 3 Yr | 12.1%* | -6.3% | 23.9% | 20.63% |
| 5 Yr | 7.6%* | -15.5% | 12.3% | 13.55% |
| 10 Yr | 7.9%* | 3.0% | 13.1% | 56.69% |
* Annualized
Return Ranking - Calendar
| Period | XTHWX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2025 | 16.1% | -21.9% | 61.0% | 36.25% |
| 2024 | -6.7% | -28.2% | 19.2% | 81.25% |
| 2023 | -8.6% | -8.6% | 19.0% | 99.38% |
| 2022 | -16.7% | -53.9% | 3.2% | 79.35% |
| 2021 | 6.7% | -39.6% | 24.2% | 25.81% |
Total Return Ranking - Trailing
| Period | XTHWX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 2.3% | -22.9% | 20.0% | 24.38% |
| 1 Yr | 36.5% | -20.4% | 134.5% | 23.13% |
| 3 Yr | 12.1%* | -6.3% | 23.9% | 20.63% |
| 5 Yr | 7.6%* | -15.5% | 12.3% | 13.55% |
| 10 Yr | 7.9%* | 3.0% | 13.1% | 56.69% |
* Annualized
Total Return Ranking - Calendar
| Period | XTHWX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2025 | 31.0% | -0.5% | 63.7% | 15.00% |
| 2024 | 4.6% | -28.2% | 19.2% | 25.63% |
| 2023 | 2.3% | -8.6% | 19.0% | 81.25% |
| 2022 | -7.6% | -53.9% | 3.7% | 37.42% |
| 2021 | 16.9% | -33.9% | 26.0% | 21.94% |
NAV & Total Return History
XTHWX - Holdings
Concentration Analysis
| XTHWX | Category Low | Category High | XTHWX % Rank | |
|---|---|---|---|---|
| Net Assets | 497 M | 6.38 M | 37.9 B | 60.63% |
| Number of Holdings | 213 | 24 | 416 | 6.25% |
| Net Assets in Top 10 | 229 M | 3.49 M | 22.8 B | 60.63% |
| Weighting of Top 10 | 41.47% | 16.2% | 79.4% | 63.13% |
Top 10 Holdings
- UnitedHealth Group Inc 7.71%
- Roche Holding AG ADR 5.40%
- AstraZeneca PLC ADR 4.61%
- Thermo Fisher Scientific Inc 4.12%
- Pfizer Inc 3.91%
- Johnson & Johnson 3.82%
- Abbott Laboratories 3.64%
- AbbVie Inc 3.54%
- Medtronic PLC 3.36%
- Anthem Inc 3.29%
Asset Allocation
| Weighting | Return Low | Return High | XTHWX % Rank | |
|---|---|---|---|---|
| Stocks | 105.50% | 88.27% | 106.13% | 2.50% |
| Bonds | 11.89% | 0.00% | 12.39% | 2.50% |
| Cash | 2.97% | 0.00% | 32.31% | 38.75% |
| Preferred Stocks | 1.79% | 0.00% | 7.86% | 21.25% |
| Convertible Bonds | 0.00% | 0.00% | 0.37% | 55.48% |
| Other | -22.15% | -22.99% | 4.13% | 98.75% |
Stock Sector Breakdown
| Weighting | Return Low | Return High | XTHWX % Rank | |
|---|---|---|---|---|
| Healthcare | 94.76% | 59.26% | 100.00% | 96.13% |
| Real Estate | 5.24% | 0.00% | 5.89% | 2.58% |
| Utilities | 0.00% | 0.00% | 0.00% | 51.61% |
| Technology | 0.00% | 0.00% | 22.69% | 54.84% |
| Industrials | 0.00% | 0.00% | 7.02% | 54.84% |
| Financial Services | 0.00% | 0.00% | 1.60% | 67.10% |
| Energy | 0.00% | 0.00% | 0.00% | 51.61% |
| Communication Services | 0.00% | 0.00% | 9.11% | 54.19% |
| Consumer Defense | 0.00% | 0.00% | 25.73% | 58.06% |
| Consumer Cyclical | 0.00% | 0.00% | 1.92% | 53.55% |
| Basic Materials | 0.00% | 0.00% | 7.16% | 69.68% |
Stock Geographic Breakdown
| Weighting | Return Low | Return High | XTHWX % Rank | |
|---|---|---|---|---|
| US | 77.78% | 60.50% | 104.41% | 88.75% |
| Non US | 27.72% | 0.00% | 36.86% | 5.63% |
Bond Sector Breakdown
| Weighting | Return Low | Return High | XTHWX % Rank | |
|---|---|---|---|---|
| Corporate | 81.57% | 0.00% | 81.57% | 1.44% |
| Cash & Equivalents | 18.43% | 0.00% | 100.00% | 8.75% |
| Derivative | 0.00% | -0.01% | 0.21% | 56.88% |
| Securitized | 0.00% | 0.00% | 0.00% | 50.36% |
| Municipal | 0.00% | 0.00% | 0.00% | 50.36% |
| Government | 0.00% | 0.00% | 29.44% | 51.08% |
Bond Geographic Breakdown
| Weighting | Return Low | Return High | XTHWX % Rank | |
|---|---|---|---|---|
| US | 8.56% | 0.00% | 11.75% | 2.50% |
| Non US | 3.33% | 0.00% | 3.33% | 1.25% |
XTHWX - Expenses
Operational Fees
| XTHWX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Expense Ratio | 1.74% | 0.08% | 4.69% | 23.75% |
| Management Fee | 1.00% | 0.03% | 1.25% | 90.00% |
| 12b-1 Fee | N/A | 0.00% | 1.00% | N/A |
| Administrative Fee | N/A | 0.03% | 0.25% | N/A |
Sales Fees
| XTHWX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Front Load | N/A | 3.50% | 5.75% | N/A |
| Deferred Load | N/A | 1.00% | 1.00% | N/A |
Trading Fees
| XTHWX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Max Redemption Fee | N/A | 1.00% | 1.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
| XTHWX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Turnover | 69.37% | 1.00% | 238.00% | 83.33% |
XTHWX - Distributions
Dividend Yield Analysis
| XTHWX | Category Low | Category High | XTHWX % Rank | |
|---|---|---|---|---|
| Dividend Yield | 11.13% | 0.00% | 6.24% | 67.50% |
Dividend Distribution Analysis
| XTHWX | Category Low | Category High | Category Mod | |
|---|---|---|---|---|
| Dividend Distribution Frequency | Monthly | Annual | Annual | Annual |
Net Income Ratio Analysis
| XTHWX | Category Low | Category High | XTHWX % Rank | |
|---|---|---|---|---|
| Net Income Ratio | 0.53% | -2.54% | 1.85% | 15.69% |
Capital Gain Distribution Analysis
| XTHWX | Category Low | Category High | Capital Mode | |
|---|---|---|---|---|
| Capital Gain Distribution Frequency | Annually | Semi-Annually | Annually |
Distributions History
| Date | Amount | Type |
|---|---|---|
| May 21, 2026 | $0.117 | OrdinaryDividend |
| Apr 22, 2026 | $0.117 | OrdinaryDividend |
| Mar 24, 2026 | $0.117 | OrdinaryDividend |
| Feb 20, 2026 | $0.117 | OrdinaryDividend |
| Jan 23, 2026 | $0.117 | OrdinaryDividend |
| Dec 31, 2025 | $0.117 | OrdinaryDividend |
| Nov 21, 2025 | $0.117 | OrdinaryDividend |
| Oct 24, 2025 | $0.117 | OrdinaryDividend |
| Sep 23, 2025 | $0.117 | OrdinaryDividend |
| Aug 22, 2025 | $0.117 | OrdinaryDividend |
| Jul 24, 2025 | $0.117 | OrdinaryDividend |
| Jun 23, 2025 | $0.117 | OrdinaryDividend |
| May 22, 2025 | $0.005 | OrdinaryDividend |
| May 22, 2025 | $0.112 | ReturnOfCapital |
| Apr 23, 2025 | $0.117 | OrdinaryDividend |
| Mar 25, 2025 | $0.117 | OrdinaryDividend |
| Feb 21, 2025 | $0.117 | OrdinaryDividend |
| Jan 24, 2025 | $0.117 | OrdinaryDividend |
| Dec 30, 2024 | $0.117 | OrdinaryDividend |
| Nov 21, 2024 | $0.117 | OrdinaryDividend |
| Oct 24, 2024 | $0.117 | OrdinaryDividend |
| Sep 23, 2024 | $0.117 | OrdinaryDividend |
| Aug 23, 2024 | $0.117 | OrdinaryDividend |
| Jul 24, 2024 | $0.117 | OrdinaryDividend |
| Jun 21, 2024 | $0.117 | OrdinaryDividend |
| May 22, 2024 | $0.117 | OrdinaryDividend |
| Apr 22, 2024 | $0.117 | OrdinaryDividend |
| Mar 20, 2024 | $0.117 | OrdinaryDividend |
| Feb 21, 2024 | $0.117 | OrdinaryDividend |
| Jan 23, 2024 | $0.117 | OrdinaryDividend |
| Dec 28, 2023 | $0.117 | OrdinaryDividend |
| Nov 21, 2023 | $0.117 | OrdinaryDividend |
| Oct 19, 2023 | $0.117 | OrdinaryDividend |
| Sep 20, 2023 | $0.117 | OrdinaryDividend |
| Aug 18, 2023 | $0.117 | OrdinaryDividend |
| Jul 19, 2023 | $0.117 | OrdinaryDividend |
| Jun 16, 2023 | $0.117 | OrdinaryDividend |
| May 19, 2023 | $0.117 | OrdinaryDividend |
| Apr 19, 2023 | $0.117 | OrdinaryDividend |
| Mar 17, 2023 | $0.117 | OrdinaryDividend |
| Feb 17, 2023 | $0.117 | OrdinaryDividend |
| Jan 19, 2023 | $0.117 | OrdinaryDividend |
| Dec 16, 2022 | $0.117 | ReturnOfCapital |
| Nov 18, 2022 | $0.117 | ReturnOfCapital |
| Oct 19, 2022 | $0.117 | ReturnOfCapital |
| Sep 19, 2022 | $0.025 | ReturnOfCapital |
| Sep 19, 2022 | $0.056 | CapitalGainLongTerm |
| Sep 19, 2022 | $0.036 | OrdinaryDividend |
| Aug 19, 2022 | $0.025 | ReturnOfCapital |
| Aug 19, 2022 | $0.036 | OrdinaryDividend |
| Aug 19, 2022 | $0.056 | CapitalGainLongTerm |
| Jul 20, 2022 | $0.056 | CapitalGainLongTerm |
| Jul 20, 2022 | $0.037 | OrdinaryDividend |
| Jul 20, 2022 | $0.025 | ReturnOfCapital |
| Jun 17, 2022 | $0.056 | CapitalGainLongTerm |
| Jun 17, 2022 | $0.024 | ReturnOfCapital |
| Jun 17, 2022 | $0.037 | OrdinaryDividend |
| May 19, 2022 | $0.024 | ReturnOfCapital |
| May 19, 2022 | $0.056 | CapitalGainLongTerm |
| May 19, 2022 | $0.037 | OrdinaryDividend |
| Apr 20, 2022 | $0.024 | ReturnOfCapital |
| Apr 20, 2022 | $0.056 | CapitalGainLongTerm |
| Apr 20, 2022 | $0.037 | OrdinaryDividend |
| Mar 18, 2022 | $0.037 | OrdinaryDividend |
| Mar 18, 2022 | $0.056 | CapitalGainLongTerm |
| Mar 18, 2022 | $0.024 | ReturnOfCapital |
| Feb 17, 2022 | $0.037 | OrdinaryDividend |
| Feb 17, 2022 | $0.056 | CapitalGainLongTerm |
| Feb 17, 2022 | $0.024 | ReturnOfCapital |
| Jan 19, 2022 | $0.056 | CapitalGainLongTerm |
| Jan 19, 2022 | $0.024 | ReturnOfCapital |
| Jan 19, 2022 | $0.037 | OrdinaryDividend |
| Dec 17, 2021 | $0.117 | ReturnOfCapital |
| Nov 18, 2021 | $0.117 | ReturnOfCapital |
| Oct 19, 2021 | $0.117 | ReturnOfCapital |
| Sep 17, 2021 | $0.104 | OrdinaryDividend |
| Sep 17, 2021 | $0.013 | ReturnOfCapital |
| Aug 19, 2021 | $0.003 | OrdinaryDividend |
| Aug 19, 2021 | $0.114 | ReturnOfCapital |
| Jul 19, 2021 | $0.003 | OrdinaryDividend |
| Jul 19, 2021 | $0.114 | ReturnOfCapital |
| Jun 17, 2021 | $0.114 | ReturnOfCapital |
| Jun 17, 2021 | $0.003 | OrdinaryDividend |
| May 19, 2021 | $0.114 | ReturnOfCapital |
| May 19, 2021 | $0.003 | OrdinaryDividend |
| Apr 19, 2021 | $0.114 | ReturnOfCapital |
| Apr 19, 2021 | $0.003 | OrdinaryDividend |
| Mar 18, 2021 | $0.003 | OrdinaryDividend |
| Mar 18, 2021 | $0.113 | ReturnOfCapital |
| Feb 18, 2021 | $0.113 | ReturnOfCapital |
| Feb 18, 2021 | $0.003 | OrdinaryDividend |
| Jan 20, 2021 | $0.113 | ReturnOfCapital |
| Jan 20, 2021 | $0.003 | OrdinaryDividend |
| Dec 17, 2020 | $0.117 | ReturnOfCapital |
| Nov 19, 2020 | $0.117 | ReturnOfCapital |
| Oct 19, 2020 | $0.117 | ReturnOfCapital |
| Sep 17, 2020 | $0.117 | ReturnOfCapital |
| Aug 19, 2020 | $0.117 | ReturnOfCapital |
| Jul 17, 2020 | $0.117 | ReturnOfCapital |
| Jun 18, 2020 | $0.117 | ReturnOfCapital |
| May 19, 2020 | $0.117 | ReturnOfCapital |
| Apr 17, 2020 | $0.117 | ReturnOfCapital |
| Mar 19, 2020 | $0.117 | ReturnOfCapital |
| Feb 19, 2020 | $0.117 | ReturnOfCapital |
| Jan 16, 2020 | $0.116 | ReturnOfCapital |
| Jan 16, 2020 | $0.001 | OrdinaryDividend |
| Dec 19, 2019 | $0.117 | OrdinaryDividend |
| Nov 19, 2019 | $0.117 | OrdinaryDividend |
| Oct 17, 2019 | $0.117 | OrdinaryDividend |
| Sep 19, 2019 | $0.117 | OrdinaryDividend |
| Aug 19, 2019 | $0.117 | OrdinaryDividend |
| Jul 18, 2019 | $0.117 | OrdinaryDividend |
| Jun 19, 2019 | $0.117 | OrdinaryDividend |
| May 17, 2019 | $0.117 | OrdinaryDividend |
| Apr 17, 2019 | $0.117 | OrdinaryDividend |
| Mar 19, 2019 | $0.117 | OrdinaryDividend |
| Feb 19, 2019 | $0.117 | OrdinaryDividend |
| Jan 17, 2019 | $0.117 | OrdinaryDividend |
| Dec 19, 2018 | $0.117 | OrdinaryDividend |
| Nov 19, 2018 | $0.117 | OrdinaryDividend |
| Oct 18, 2018 | $0.117 | OrdinaryDividend |
| Sep 19, 2018 | $0.117 | OrdinaryDividend |
| Aug 17, 2018 | $0.117 | OrdinaryDividend |
| Jul 19, 2018 | $0.117 | OrdinaryDividend |
| Jun 19, 2018 | $0.117 | OrdinaryDividend |
| May 17, 2018 | $0.117 | OrdinaryDividend |
| Apr 19, 2018 | $0.117 | OrdinaryDividend |
| Mar 19, 2018 | $0.117 | OrdinaryDividend |
| Feb 16, 2018 | $0.117 | OrdinaryDividend |
| Jan 18, 2018 | $0.117 | OrdinaryDividend |
| Dec 15, 2017 | $0.117 | OrdinaryDividend |
| Nov 17, 2017 | $0.117 | OrdinaryDividend |
| Oct 18, 2017 | $0.117 | OrdinaryDividend |
| Sep 15, 2017 | $0.117 | OrdinaryDividend |
| Aug 17, 2017 | $0.117 | OrdinaryDividend |
| Jul 13, 2017 | $0.117 | OrdinaryDividend |
| Jun 15, 2017 | $0.117 | OrdinaryDividend |
| May 17, 2017 | $0.117 | OrdinaryDividend |
| Apr 12, 2017 | $0.117 | OrdinaryDividend |
| Mar 16, 2017 | $0.117 | OrdinaryDividend |
| Feb 16, 2017 | $0.117 | OrdinaryDividend |
| Jan 18, 2017 | $0.117 | OrdinaryDividend |
| Dec 15, 2016 | $0.117 | OrdinaryDividend |
| Nov 17, 2016 | $0.117 | OrdinaryDividend |
| Oct 18, 2016 | $0.117 | OrdinaryDividend |
| Sep 15, 2016 | $0.117 | OrdinaryDividend |
| Aug 17, 2016 | $0.117 | OrdinaryDividend |
| Jul 14, 2016 | $0.117 | OrdinaryDividend |
| Jun 16, 2016 | $0.117 | OrdinaryDividend |
| May 17, 2016 | $0.117 | OrdinaryDividend |
| Apr 14, 2016 | $0.117 | OrdinaryDividend |
| Mar 16, 2016 | $0.117 | OrdinaryDividend |
| Feb 17, 2016 | $0.117 | OrdinaryDividend |
| Jan 20, 2016 | $0.117 | OrdinaryDividend |
| Dec 17, 2015 | $0.117 | OrdinaryDividend |
| Nov 17, 2015 | $0.117 | OrdinaryDividend |
| Oct 15, 2015 | $0.117 | OrdinaryDividend |
| Sep 17, 2015 | $0.117 | OrdinaryDividend |
| Aug 18, 2015 | $0.117 | OrdinaryDividend |
XTHWX - Fund Manager Analysis
Managers
Daniel Omstead
Start Date
Tenure
Tenure Rank
Jun 26, 2015
6.93
6.9%
Omstead is president and chief executive officer of Tekla Capital Management, formerly known as Hambrecht & Quist Capital Management, Inc. Before joining the adviser, Omstead was president and CEO of Reprogenesis, Inc., a private development stage biotech company developing therapies in the field of regenerative medicine. Before joining Reprogenesis, he was senior vice president, research and development at Cytotherapeutics, Inc., a public biotech company that developed CNS therapies.
Tenure Analysis
| Category Low | Category High | Category Average | Category Mode |
|---|---|---|---|
| 0.02 | 24.72 | 8.08 | 0.25 |